GF-CART01
B cell malignancies
PreclinicalActive
Key Facts
About GenomeFrontier Therapeutics
Taiwan biotech leveraging virus‑free gene‑editing platforms to create CAR‑T/TCR‑T cell therapies for cancer.
View full company profileB cell malignancies
Taiwan biotech leveraging virus‑free gene‑editing platforms to create CAR‑T/TCR‑T cell therapies for cancer.
View full company profile